Enhanced immunogenicity of Plasmodium falciparum peptide vaccines using a topical adjuvant containing a potent synthetic Toll-like receptor 7 agonist, imiquimod
about
Plasmodium cellular effector mechanisms and the hepatic microenvironmentToll Like Receptors Signaling Pathways as a Target for Therapeutic InterventionsIn vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants.Topical resiquimod protects against visceral infection with Leishmania infantum chagasi in mice.IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunityAn update on the use of laser technology in skin vaccination.Adjuvants for Leishmania vaccines: from models to clinical application.Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope.Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complexPlasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.Skin scarification with Plasmodium falciparum peptide vaccine using synthetic TLR agonists as adjuvants elicits malaria sporozoite neutralizing immunityProtective humoral immunity elicited by a needle-free malaria vaccine comprised of a chimeric Plasmodium falciparum circumsporozoite protein and a Toll-like receptor 5 agonist, flagellin.Rhesus macaque and mouse models for down-selecting circumsporozoite protein based malaria vaccines differ significantly in immunogenicity and functional outcomesToll-like receptor 7 agonist imiquimod in combination with influenza vaccine expedites and augments humoral immune responses against influenza A(H1N1)pdm09 virus infection in BALB/c mice.The application of Toll like receptors for cancer therapy.The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties.Toll-like receptor signaling in parasitic infections.Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research.Immunogenicity of intradermal trivalent influenza vaccine with topical imiquimod: a double blind randomized controlled trial.Fatty Acid-Mimetic Micelles for Dual Delivery of Antigens and Imidazoquinoline Adjuvants.Topical resiquimod: a promising adjuvant for vaccine development?
P2860
Q28081143-3B4E8C1B-D625-4C39-AF6F-AC0C6AB61A7DQ29248835-96DF9555-3432-49E6-9FE7-E349EB0188B5Q33901007-55CD7D6A-2CB8-457C-AE66-63F05BAFFB10Q34260736-4050FA7E-7F79-4D26-BD0D-D865C984ED0CQ34400813-F6700700-51F5-4E17-A345-B7BA04B9E2D6Q34461933-6785AC28-4FF0-4990-B619-C8CB356F2B79Q35017651-C6E9D7D1-4D37-409E-B625-59678BF83342Q36021357-CEC837DA-6644-4854-9D08-B7ECDABF44EEQ36083687-CF778351-B117-4D76-A90F-FD39FF8B02AFQ36434929-E819AF31-5F1C-44A7-9726-FCBB2FA67413Q36726849-3EB69C9E-8652-4D60-AF55-451B474272FAQ37254129-975EF68E-689D-4E8F-84BC-53DBE1D20FA0Q37336064-22A94C91-4333-4434-ACC9-B52E2F112B43Q37696415-0A3C6B6E-F845-4D10-B884-907F1F8F4941Q37712843-1E670569-276E-44F6-9B66-95DD607F7493Q37808111-ECBCEDD9-0A28-4128-B692-CCDEE7B8644CQ38072603-3CCDF511-A941-43E2-9006-3139D3729A8EQ38432017-F5F45661-5C75-489D-922F-1603EC7E7204Q40752357-C58CD182-BFE5-49AF-B38D-E1E315FD41E3Q42204647-FE9AEA8F-0C38-4D97-B190-8CF1A7F2FEA8Q42378276-8FC865FB-6079-42A4-847E-87BD1B1ED405Q43215434-CE83C612-3CD1-4E45-A7CE-EBDEC9844AA0
P2860
Enhanced immunogenicity of Plasmodium falciparum peptide vaccines using a topical adjuvant containing a potent synthetic Toll-like receptor 7 agonist, imiquimod
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhanced immunogenicity of Pla ...... receptor 7 agonist, imiquimod
@en
Enhanced immunogenicity of Pla ...... receptor 7 agonist, imiquimod.
@nl
type
label
Enhanced immunogenicity of Pla ...... receptor 7 agonist, imiquimod
@en
Enhanced immunogenicity of Pla ...... receptor 7 agonist, imiquimod.
@nl
prefLabel
Enhanced immunogenicity of Pla ...... receptor 7 agonist, imiquimod
@en
Enhanced immunogenicity of Pla ...... receptor 7 agonist, imiquimod.
@nl
P2093
P2860
P356
P1476
Enhanced immunogenicity of Pla ...... receptor 7 agonist, imiquimod
@en
P2093
Caroline Othoro
Dean Johnston
Elizabeth Nardin
Jean-Claude Bystryn
Jonathan Soverow
Rebecca Lee
P2860
P304
P356
10.1128/IAI.00974-08
P407
P577
2008-12-01T00:00:00Z